- Investing Ideas
- /
- Australian Healthcare Undervalued Stocks Based On Cash Flows
Australian Healthcare Undervalued Stocks Based On Cash Flows
Results
4
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
Integral Diagnostics
Market Cap: AU$836.1m
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.25
7D
3.7%
1Y
-7.0%
PolyNovo
Market Cap: AU$759.9m
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
PNV
AU$1.10
7D
4.3%
1Y
-45.3%
Nanosonics
Market Cap: AU$1.5b
Operates as an infection prevention company globally.
NAN
AU$4.82
7D
2.3%
1Y
67.9%
Sigma Healthcare
Market Cap: AU$34.5b
Operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally.
SIG
AU$2.99
7D
0.7%
1Y
n/a